Gastrointestinal stromal tumours of
the small intestine, including duodenum (GIST)
Gastrointestinal
stromal tumour more commonly occurs in the stomach. GIST is by far the most common stromal tumour
in the duodenum2.
Epidemiology
Age range was from 10 to 88 years, median
56 years2.
Clinical features
The
most common manifestation is with bleeding, usually chronic, causing anaemia,
less often acute with melena2.
The
small intestines are the most common site for GIST
in association with type I neurofibromatosis, in which context
they are commonly multiple2.
Histopathology
The pathology resembles that at other sites.
A feature not observed outside the duodenum is a haemangioma-like vascular
proliferation, which is sometimes glomeruloid2.
Immunohistochemistry
CD117 |
15/161, 109/1092,
18/183 |
CD34 |
11/161, 49/912,
7/183 |
vimentin |
16/161, 18/183 |
SMA |
12/161, 38/972,
14/183 |
CD34
and SMA |
11/912 |
bcl-2 |
15/161 |
PGP9.5 |
10/161 |
Desmin |
0/902,
0/183 |
S-100 |
19/972,
14/18(few
cells stained)3 |
AE1/3 |
0/183 |
CK18 |
5/612 |
CK7 |
0/532 |
CK19 |
0/612 |
EMA |
0/183 |
GFAP |
0/572 |
Neurofilament |
2/161, 8/572 |
NSE |
15/161 |
tau |
12/161 |
synaptophysin |
3/161 |
Expression
of SMA and S-100 appears
to be more common in GISTs of the small bowel than in those of the stomach, with less common
expression of CD34.
Differential diagnosis
Prognosis
Patients with recurrence, metastasis or
died of disease:
Based on a series of
duodenal GISTs2 |
<5 mitoses/50 HPF |
>5 mitoses /50 HPF |
< 2 cm |
0/12 |
0 |
2-5 cm |
4/48(three
of these deaths occurred after more than 5 years of disease) |
9/18 |
>5 cm |
12/35 |
18/21 |
Unassigned |
6/6 |
Total |
49/140(five recurrences were
more than 10 years after excision of the primary tumour) |
Spread occurs within the abdominal cavity,
to liver, bones or lungs, rarely ovaries, never to lymph nodes.
References
1
Chambonniere,
M. L., Mosnier-Damet, M., Mosnier, J. F. Expression of microtubule-associated
protein tau by gastrointestinal stromal tumors. Human Pathol 2001;32:1166-1173.
2
Miettinen,
M., J. Kopczynski, et al. (2003). "Gastrointestinal stromal tumors,
intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic,
immunohistochemical, and molecular genetic study of 167 cases." Am
J Surg Pathol 27(5): 625-41.
3 Hasegawa,
T., Y. Matsuno, et al. (2002). "Gastrointestinal stromal tumor: consistent
CD117 immunostaining for diagnosis, and prognostic classification based
on tumor size and MIB-1 grade." Hum Pathol 33(6): 669-76.
4
This page last
revised 28.1.2006.
©SMUHT/PW
Bishop